Guyer William Insider Trades

Insider Trading History

Track insider trading activity for Guyer William. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $482k 4,313 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.2k 328 shares
$113.38
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $2.27M 20,285 shares
Last Trade
Aug 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.86M 16,300 shares
$114.23
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $12.3M 110,000 shares
Last Trade
Aug 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.86M 16,300 shares
$114.23
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $979k 8,755 shares
Last Trade
Aug 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.85M 16,300 shares
$113.43
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $859k 7,685 shares
Last Trade
Aug 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$406k 3,700 shares
$109.74
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $446k 3,985 shares
Last Trade
Aug 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$419k 3,700 shares
$113.12
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $14.1M 126,300 shares
Last Trade
Aug 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$406k 3,700 shares
$109.74
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $2.68M 23,985 shares
Last Trade
Jul 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.88M 20,000 shares
$94.04
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $552k 4,937 shares
Last Trade
Jul 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.86M 20,000 shares
$93.13
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $14.5M 130,000 shares
Last Trade
Jul 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.88M 20,000 shares
$94.04
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $446k 3,985 shares
Last Trade
Jun 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.41M 20,000 shares
$70.60
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $2.68M 23,985 shares
Last Trade
Jun 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.42M 20,000 shares
$71.20
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $16.8M 150,000 shares
Last Trade
Jun 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.42M 20,000 shares
$71.20
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $446k 3,985 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 1,754 shares
$70.44
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $2.49M 22,231 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 20,000 shares
$51.33
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $249k 2,231 shares
Last Trade
May 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.04M 20,000 shares
$51.83
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $19M 170,000 shares
Last Trade
May 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 20,000 shares
$51.33
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $249k 2,231 shares
Last Trade
Apr 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$819k 20,000 shares
$40.97
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $2.49M 22,231 shares
Last Trade
Apr 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$834k 20,000 shares
$41.69
$111.81
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Development Officer
Holding Value $21.2M 190,000 shares
Last Trade
Apr 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$834k 20,000 shares
$41.69
$111.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up